This inventor holds 1 USPTO granted patent. Top assignee: Chia Tai Tianqing Pharmaceutical Group Co., Ltd.. Active years: 2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2022
Title: Jun Shen - Innovator in Cancer Treatment
Introduction
Jun Shen is a notable inventor based in Jiangsu, China. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of nasopharyngeal carcinoma. His innovative work has the potential to impact cancer treatment positively.
Latest Patents
Jun Shen holds a patent for a quinoline derivative aimed at treating nasopharyngeal carcinoma. This invention provides a quinoline derivative for the treatment of this type of cancer and outlines its use in the preparation of a pharmaceutical composition for tumor treatment. This patent showcases his commitment to advancing medical science and improving patient outcomes.
Career Highlights
Jun Shen is associated with Chia Tai Tianqing Pharmaceutical Group Co., Ltd., where he continues to work on groundbreaking pharmaceutical innovations. His role in this esteemed company allows him to collaborate with other talented professionals in the field.
Collaborations
Some of his notable coworkers include Shanchun Wang and Xi Han. Their collective expertise contributes to the advancement of research and development in cancer treatment.
Conclusion
Jun Shen's work exemplifies the spirit of innovation in the pharmaceutical industry. His contributions, particularly in the treatment of nasopharyngeal carcinoma, highlight the importance of research and development in improving healthcare solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile